Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01LEV
|
|||
| Former ID |
DNC007474
|
|||
| Drug Name |
3-((3-bromothiophen-2-yl)methylene)indolin-2-one
|
|||
| Synonyms |
CHEMBL230414; 3-((3-bromothiophen-2-yl)methylene)indolin-2-one
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H8BrNOS
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=CC3=C(C=CS3)Br)C(=O)N2
|
|||
| InChI |
1S/C13H8BrNOS/c14-10-5-6-17-12(10)7-9-8-3-1-2-4-11(8)15-13(9)16/h1-7H,(H,15,16)/b9-7+
|
|||
| InChIKey |
ZGCKMTQNGWQKEN-VQHVLOKHSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Pharmacophore modeling and in silico screening for new KDR kinase inhibitors. Bioorg Med Chem Lett. 2007 Apr 15;17(8):2126-33. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.